Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Interfering with the CCL2-glycosaminoglycan axis as a potential approach to modulate neuroinflammation.
Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trial.
Neuroprotective effect of nitric oxide donor isosorbide-dinitrate against oxidative stress induced by ethidium bromide in rat brain.
Alpha-tocopherol ameliorates experimental autoimmune encephalomyelitis through the regulation of Th1 cells.
Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism.
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients.
Hormone replacement in menopausal women with multiple sclerosis: Looking back, thinking forward.
Schwann cell mitochondria as key regulators in the development and maintenance of peripheral nerve axons.
Myelin plasticity in the central nervous system.
Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders.
Field inhomogeneity correction for gradient echo myelin water fraction imaging.
Postural tremor and chronic inflammatory demyelinating polyneuropathy.
Proof of Principle: Coronin 1A - An Intrinsic Modulator of T Lymphocyte Function.
Assessing and treating pain associated with stroke, multiple sclerosis, cerebral palsy, spinal cord injury and spasticity. Evidence and recommendations from the Italian Consensus conference on Pain in Neurorehabilitation.
Ongoing increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: A 50-year study.
Multiple Sclerosis and Obesity: Possible Roles of Adipokines.
Addition of a general surgeon without addition of appropriate support is inadequate to improve outcomes of trauma patients in a rural setting: a cohort study of 1962 consecutive patients.
Accelerated generation of oligodendrocyte progenitor cells from human induced pluripotent stem cells by forced expression of Sox10 and Olig2.
Defects in the COG complex and COG-related trafficking regulators affect neuronal Golgi function.
Screening for SH3TC2 gene mutations in a series of demyelinating recessive Charcot-Marie-Tooth disease (CMT4).
Nuclear factor erythroid 2-related factor 2 is a critical target for the treatment of glucocorticoid-resistant lupus nephritis.
Monozygotic twins discordant for narcolepsy type 1 and multiple sclerosis.
The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy.
Systemic Lupus Erythematosus With Acute Inflammatory Demyelinating Polyneuropathy: A Case Report and Review of the Literature.
Grey matter atrophy is associated with disability increase in natalizumab-treated patients.
Pages
« first
‹ previous
…
835
836
837
838
839
840
841
842
843
…
next ›
last »